Not surprising a bit of money coming off the table. It's had a stellar run. Still capable of plus 20% per annanum for years to come. Sure Mny has competition but it's not crippling.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025